The Pathogenesis of Primary Cicatricial Alopecias

    October 2010 in “ The American Journal of Pathology
    Matthew Harries, Ralf Paus
    Image of study
    TLDR The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.
    The document from November 2010 reviews the pathogenesis of primary cicatricial alopecias (PCAs), which are disorders causing permanent hair loss due to the destruction of hair follicle stem cells, often linked to autoimmune disease. It discusses the classification of PCAs based on inflammatory cells and the lack of understanding of the signaling pathways leading to immune attacks on hair follicle stem cells. The review emphasizes the need for further research to develop effective treatments and to understand the immunopathology of epithelial stem cells. It also explores the role of immune privilege collapse, CD200 expression loss, cell-mediated cytotoxicity, proinflammatory responses, apoptosis, sebaceous gland dysfunction, and PPARγ deficiency in PCA pathogenesis. The document suggests that PPAR-γ agonists may be promising for PCA therapy and highlights the potential role of environmental triggers, genetic factors, and stress-induced inflammation in PCA development. It concludes with a call for more attention to PCAs from researchers to improve diagnosis and treatment, and suggests a potential reclassification of PCAs based on molecular pathways.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 267 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 2 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 5 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  122 upvotes 4 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

      community I love Costco. Fin is less than $3 per month without insurance.

      in Finasteride/Dutasteride  128 upvotes 7 months ago
      The conversation discusses the affordability of finasteride for hair loss treatment, with users sharing that it can be obtained for less than $3 per month at Costco without insurance, and the cost can be further reduced by getting a year's prescription at once. Some users also mention getting prescriptions from their primary care physician or online services.

    Related Research

    7 / 7 results